Sciex has inked a deal to resell the AQSPro from RedShift Bioanalytics throughout the U.S., providing more biopharmaceutical labs with access to critical data.
The technology integrates automated sample handling for 24- and 96- well plate formats and offers a unique microfluidic system and a quantum cascade laser-based optical system. Real-time background subtraction eliminates the need to dialyze samples, and the AQSPro can measure a range of native sample concentrations from less than 0.1mg/ml to greater than 200 mg/ml.
